0001209191-21-037144.txt : 20210602
0001209191-21-037144.hdr.sgml : 20210602
20210602161143
ACCESSION NUMBER: 0001209191-21-037144
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210602
DATE AS OF CHANGE: 20210602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heyman Richard A.
CENTRAL INDEX KEY: 0001584759
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39539
FILM NUMBER: 21989229
MAIL ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001699382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463218129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 642-6664
MAIL ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-01
0
0001699382
PMV Pharmaceuticals, Inc.
PMVP
0001584759
Heyman Richard A.
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY
NJ
08512
1
0
0
0
Common Stock
2021-06-01
4
M
0
1950
2.95
A
1950
I
See footnote
Common Stock
2021-06-01
4
S
0
1392
32.1509
D
558
I
See footnote
Common Stock
2021-06-01
4
S
0
553
33.6105
D
5
I
See footnote
Common Stock
2021-06-01
4
S
0
5
34.67
D
0
I
See footnote
Common Stock
2021-06-01
4
M
0
975
2.95
A
975
I
See footnote
Common Stock
2021-06-01
4
S
0
743
32.1618
D
232
I
See footnote
Common Stock
2021-06-01
4
S
0
230
33.7465
D
2
I
See footnote
Common Stock
2021-06-01
4
S
0
2
34.67
D
0
I
See footnote
Common Stock
2021-06-01
4
M
0
975
975.00
A
975
I
See footnote
Common Stock
2021-06-01
4
S
0
764
32.1507
D
211
I
See footnote
Common Stock
2021-06-01
4
S
0
209
33.7882
D
2
I
See footnote
Common Stock
2021-06-01
4
S
0
2
34.67
D
0
I
See footnote
Stock Option (right to buy)
2.95
2021-06-01
4
M
0
1950
0.00
D
2027-08-16
Common Stock
1950
15901
I
See footnote
Stock Option (right to buy)
2.95
2021-06-01
4
M
0
975
0.00
D
2027-08-16
Common Stock
975
7951
I
See footnote
Stock Option (right to buy)
2.95
2021-06-01
4
M
0
975
0.00
D
2027-08-16
Common Stock
975
7951
I
See footnote
Stock Option (right to buy)
2.95
2027-08-16
Common Stock
11901
11901
D
The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (7), (9) and (10) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.055 to $33.875, inclusive.
The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.02 to $32.46, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive.
The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.815, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive.
All of the shares subject to the option are vested and immediately exercisable.
The shares subject to the option are subject to an early exercise provision and are immediately exercisable. One forty-eighth of the shares subject to the option vested on September 17, 2017, and an additional one forty-eighth of the shares subject to the option shall vest each month thereafter.
/s/ Winston Kung, by power of attorney
2021-06-02